
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1035 | 922 | 1077 | 1240 | 1430 | 1568 |
Fund Return | 3.51% | -7.79% | 7.65% | 7.42% | 7.42% | 4.6% |
Place in category | 310 | 371 | 328 | 105 | 81 | 83 |
% in Category | 85 | 100 | 90 | 29 | 25 | 38 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JHancock Disciplined Value Mid Cap | 13.28B | -4.23 | 6.73 | 8.41 | ||
JHancock Disciplined Value I | 7.72B | -2.09 | 8.94 | 8.76 | ||
John Hancock Variable Insurance Tri | 7.06B | -5.03 | 11.81 | 11.97 | ||
JHVIT Strategic Equity Allocation T | 6.65B | -0.28 | 10.33 | 9.07 | ||
JHancock Disciplined Value Mid Cap6 | 5.95B | -4.19 | 6.85 | 8.53 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Dodge & Cox International Stock | 39.93B | 11.94 | 10.26 | 4.78 | ||
Fidelity Series International VVV | 15.5B | 18.20 | 15.00 | 6.62 | ||
Causeway International Value Instl | 13.32B | 11.48 | 15.01 | 5.76 | ||
Vanguard International Value Inv | 11.94B | 6.02 | 7.04 | 4.30 | ||
DFA International Value I | 9.99B | 13.39 | 12.57 | 5.94 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 3.64 | 91.68 | +0.85% | |
BNP Paribas | FR0000131104 | 3.18 | 79.05 | +2.00% | |
BAE Systems | GB0002634946 | 2.52 | 1,665.50 | -1.33% | |
Sandoz | CH1243598427 | 2.52 | 37.80 | -0.60% | |
AstraZeneca | GB0009895292 | 2.45 | 10,272.0 | +0.31% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review